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Abstract: A new screening technique for neonatal jaundice is proposed 
exploiting the yellow discoloration in the sclera. It involves taking digital 
photographs of newborn infants’ eyes (n = 110) and processing the pixel 
colour values of the sclera to predict the total serum bilirubin (TSB) levels. 
This technique has linear and rank correlation coefficients of 0.75 and 0.72 
(both p<0.01) with the measured TSB. The mean difference ( ± SD) is 0.00 
± 41.60 µmol/l. The receiver operating characteristic curve shows that this 
technique can identify subjects with TSB above 205 µmol/l with sensitivity 
of 1.00 and specificity of 0.50, showing its potential as a screening device. 
©2015 Optical Society of America 
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1. Introduction 
Neonatal jaundice is a common condition affecting newborn babies - 60% of term infants and 
80% of preterm infants in the first week of life, and 10% of breastfed babies are still 
jaundiced at 4 weeks old [1]. It is caused by increased red blood cell breakdown or decreased 
liver function, usually a physiological process, nonetheless causing an accumulation of 
bilirubin. In most cases no treatment is required. However, if the total serum bilirubin (TSB) 
level exceeds an age dependent treatment threshold [1], phototherapy has been shown to 
reduce the TSB level to avoid kernicterus, a condition whereby a high level of bilirubin has 
crossed the blood brain barrier causing short and long term neurological dysfunction. 
Jaundice can also indicate other life threatening conditions. For instance, haemolytic 
disease of the newborn (a condition in which antibodies from the mother attack the newborn’s 
red blood cells), neonatal infection and liver diseases can all cause bilirubin levels to rise [2]. 
Early diagnosis of these pathological conditions would allow urgent treatments to be 
administered in a timely fashion, improving the chance of recovery significantly. 
In the UK newborns who have had a low risk perinatal course are discharged from 
hospital within 1-2 days of birth. They and those born at home are routinely visited by a 
community midwife who assesses their wellbeing with respect to feeding, weight gain and 
jaundice. If the baby appears jaundiced the midwife should measure the bilirubin level either 
with a transcutaneous bilirubinometer (TcB) or with a blood sample. If the baby appears 
unwell or the bilirubin measurement exceeds 250 µmol/l, the baby should be referred to the 
paediatric team in the nearest hospital. In a worldwide setting there is a wide variation in the 
availability of community midwives and local paediatric teams. A screening tool using digital 
photography (e.g. a mobile phone camera) could have wide applications in settings where 
TcBs and blood tests are too expensive and difficult to obtain. 
One noticeable feature of jaundiced patients is the appearance of yellow discoloration on 
their skin and sclera caused by a higher level of TSB (yellow in colour) in the blood. It is 
visually detectable when TSB levels exceed 85 µmol/l. The degree of the yellow 
discoloration is dependent on the TSB level. An experienced healthcare worker can often 
identify jaundiced patients by visual inspection. The extent of neonatal jaundice can also be 
quantified by a 5-point scale first proposed by Kramer [3–5]. However, colour perception can 
be severely influenced by the ambient lighting and the skin pigment [5]. Such screening 
practice is therefore unable to provide an objective, reliable and accurate result [3]. 
For a more quantitative measurement, customised spectrometers have been developed 
which illuminate the skin with control lighting in direct contact and evaluate the reflected 
light at multiple wavelengths. Currently, the two most popular commercial TcBs include 
BiliChek (Philips Healthcare) and Jaundice Meter JM102/JM103 (Draeger Medical Inc., 
previously marketed by Konica Minolta Inc.) [5–16]. The skin pigment is the most influential 
confounding factor for the skin colour approach. To minimise its effect, the two TcBs adopt 
two very different approaches: BiliChek exploits 137 wavelengths in the visible spectrum 
between 380 and 760 nm to resolve the concentrations of melanin, haemoglobin, bilirubin and 
dermis based on their known absorption spectra [7, 17]; JM102/JM103, on the other hand, 
only uses two colours of light in blue and green (with peak wavelengths of 450 nm and 550 
nm), as well as a special probe design which allows the reflected light to be measured by two 
detectors at two different distances. The two optical density signals measured in this way 
account for light with two different penetration depths beneath the skin, one deeper than the 
other. The difference between the two signals is therefore more sensitive to the deeper 
subcutaneous tissue where the effect of skin pigment is minimised [7, 17]. 
A recent study also shows that a smartphone’s camera (iPhone 4S) can be used to predict 
TSB level based on the skin colour [18]. This approach essentially makes use of only three 
broadband colours (red, green and blue) that can be detected by a conventional smartphone’s 
camera. This technique converts the three base colours into 2 colour spaces and uses 5 
different machine learning algorithms to predict the TSB level. 
This current study reports an alternative approach based on the sclera colour to predict 
bilirubin level and quantify jaundice. The main advantage is that the sclera is less influenced 
by pigments such as melanin. Healthy sclera is white, independent of the ethnicity of the 
subject. Without the influence of a major confounding factor, the quantification of the 
yellowness and therefore the prediction of bilirubin level become much easier. 
Our study involves a digital camera which is used to take photos of newborn infants’ eyes 
and does not require any contact with the infants. The digital image is then analysed by a 
computer program written in Matlab, a high-level technical computing language. Preliminary 
results were presented at an international conference in July 2014 [19]. The sample size has 
since been expanded and the methodology improved, as reported in this paper. The ultimate 
aim of this work is to develop a screening tool which allows more effective referral of 
suspected patients for blood tests, rather than replacing them completely. 
2. Methods 
2.1 Study protocol and data collection 
The study has been approved by the National Research Ethics Service Committee (London – 
City Road and Hampstead). The data were collected in the Advanced Neonatal Nurse 
Practitioner Clinic at University College London Hospital. The majority of these babies were 
referred by midwives conducting a routine health check after discharge from the hospital. 
Some appointments were made for babies with pre-existing prolonged or physiological 
jaundice. As the TSB blood test formed part of the routine clinical procedure during the 
consultation, no further blood sampling was required specifically for this study. The 
photographs were taken before the blood test as babies tended to be more compliant at this 
time. The results for the blood test were processed within twenty minutes thereafter to prevent 
any error from short-term fluctuations in bilirubin measurements. 
The camera used was a Nikon D3200, which had a 24.6 megapixel CMOS sensor, with a 
prime macro lens of 60 mm focal length. Manual focus was used to ensure that the sclera was 
in focus and programmed auto mode was selected. This allowed the shutter speed and 
aperture size to vary depending on light entering the sensor to prevent over/under exposure. 
The ISO value (sensitivity of the digital sensor to light) was kept at ISO 1600 as a 
compromise between maintaining fast shutter speed and allowing enough light to expose the 
picture correctly. White balance was also maintained at the ‘4’ setting for fluorescent lighting 
and kept constant to ensure that colour temperature did not influence colour analysis on a 
picture-to-picture basis. A customised colour chart was utilised to match the colour of the 
sclera to a reference value on the chart so that any yellow difference in sclera colour can be 
correctly associated with a physiological effect rather than a change in spectrum of ambient 
lighting. The images were captured in RAW format to preserve as much tonal information as 
possible for each image taken. 
2.2 Subjects 
A total of 133 newborn infants were photographed for this study. Since the ambient lighting 
can seriously affect the result of this study, only the 110 samples taken in a specific clinic 
room have been included in the subsequent analysis. The reasons for exclusion are: 18 
samples were collected from other locations, 2 samples had erroneous colour channel 
responses, 1 baby would not fully open his eyes, and 2 TSB blood samples could not be 
recorded. Figures 1(a) and 1(b) show the distribution of TSBs in relation to the gestational 
and postnatal ages, respectively. As expected, Fig. 1(b) shows that the TSB tends to drop with 
the postnatal age. The database includes 67 white and 43 non-white infants. 
 
Fig. 1. The distribution of total serum bilirubin levels in relation to (a) gestational, and (b) 
postnatal ages (n = 110). 
2.3 Optical properties of the sclera 
The sclera is often known as “the white of the eye” which is the opaque, outer layer of the 
eye, surrounding the iris. The sclera is mainly composed of collagen, elastin, proteoglycans 
and glycoproteins [20]. Since the collagen has a slow turnover, the sclera has a low metabolic 
rate and requires only a low blood supply. In comparison to other parts of the body, e.g., skin, 
the sclera is less vascularised which also means that the colour of a healthy sclera is less 
influenced by the colour of the blood. In newborn infants, the sclera is thin and often appears 
blue, revealing the colour of the underlying uveal layer [20]. 
The optical properties of human sclera have been studied previously [21], showing that 
the optical transport scattering coefficient decreases monotonically from 370 nm to 1300 nm, 
similar to the general spectral characteristics of biological tissues. The study also shows that 
between 400 and 900 nm, the absorption coefficient of the human sclera has a simple spectral 
trend and does not have the spectral characteristics found in rabbit and pig sclera which are 
influenced by the scleral melanin unique only to animals [21]. Since the human sclera is free 
of melanin, it appears white in all ethnicities. 
The sclera is overlaid by the clear, lubricating layer conjunctiva, which some have argued 
is the main origin of the yellow discolouration associated with a higher level of bilirubin in 
jaundiced patients [22, 23]. It has been pointed out that the bilirubin has a strong affinity for 
elastin and it is the innermost layer of conjunctiva and the most superficial part of the sclera 
that are rich in elastic fibres, and therefore account for the yellow discoloration [22]. Some 
have simply noted that the bilirubin is mainly deposited in the vascular conjunctiva rather 
than the avascular sclerae [23]. While acknowledging the subtlety in the interpretation, we 
have adopted the more common term of “sclera colour” to describe the “combined colour” of 
conjunctiva and sclera in this paper. 
2.4 Signal analysis 
The raw images were originally saved in Nikon’s proprietary NEF format, and then converted 
into TIF format using Nikon’s ViewNX 2 software. These images were analysed using the 
mathematical software Matlab. The pixel coordinates of the sclera, skin (for comparison 
purpose) and the reference colour were manually identified in an image viewer. The reference 
colour was taken as the white patch in the colour chart. Figure 2 shows an example of pixels 
identified in this way. Three colour indexes for red, green and blue, represented by R, G and 
B here, were calculated by averaging 900 neighbouring pixels (30 × 30 region) centred on the 
pre-defined pixel coordinates. This process resulted in colour indexes: Reye, Geye and Beye for 
the sclera, Rskin, Gskin and Bskin for the skin, and Rref, Gref and Bref for the reference colour. 
Normalised versions of the colour indexes were also calculated for both the sclera and skin, 
e.g., Reye,nor = Reye / Rref is the normalised red colour index of the sclera. The normalisation can 
be considered as a colour balancing process in digital photography [24]. 
The next step was to develop a multivariate model based on the measured TSB levels and 
colour indexes in the database [25]. The multiple linear regression was performed using 
Matlab and its Statistics and Machine Learning Toolbox. Using colour indexes as the 
independent variables and the measured TSB values as dependent variables (y), a quadratic 
model was developed: 
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 (1) 
where yeye is the predicted TSB value, coefficients C0 = 373, C1 = −3385, C2 = 5137, C3 = 
−2391, C4 = −14945, C5 = 1987, C6 = 7163, C7 = 8680, C8 = 1295 and C9 = −3906. This 
quadratic model was chosen to provide a reasonably high R-squared value while avoiding 
overfitting the data, as in the case of some higher order polynomial models. By performing 
multiple linear regression on four sets of colour indexes (Rskin/Gskin/Bskin, 
Rskin,nor/Gskin,nor/Bskin,nor, Reye/Geye/Beye and Reye,nor/Geye,nor/Beye,nor), four models were produced 
which could then be used to predict four sets of TSB levels: yskin, yskin,nor, yeye and yeye,nor . 
 Fig. 2. An example of the image collected in the UCL Hospitals. The colour chart is shown on 
the left. The pixel values for the sclera, skin and white reference have been used in the 
processing. (This image has been media consented by the parents). 
2.5. Statistical analyses 
The statistical analyses focused on comparing the measured and predicted TSB levels in 
terms of their correlation, bias, sensitivity and specificity as a screening tool. The linear 
correlation between the measured and predicted TSB levels was assessed by calculating 
Pearson’s linear correlation coefficient r [26]. For a non-parametric correlation with less 
influence from outliers, Spearman’s rank correlation coefficient ρ was calculated [26]. To 
assess the agreement between the conventional and new techniques, Bland-Altman analysis 
was carried out [27]. 
Since the ultimate aim of this work is to develop a screening tool which can make a binary 
decision (referral or non-referral), the accuracy of detecting subjects above a certain TSB 
screening level (ysc) is also assessed using the receiver operating characteristic (ROC) curve 
[28]. The ROC curves have been calculated based on the predicted TSB levels, with reference 
to the measured TSB levels as the true answers. Suppose the new technique aims to identify 
subjects with a TSB level above a screening threshold, e.g., > ysc = 205 µmol/l. If one uses a 
low cut-off threshold (ycut) of 50 µmol/l (i.e. all subjects with predicted TSB levels above 50 
µmol/l would be considered to have TSB levels above 205 µmol/l), the true positive rate 
(TPR) would be very high, albeit at the expense of a high false positive rate (FPR). As ycut 
increases, both the TPR and FPR would drop in a non-linear fashion. The ROC curve 
summarises the TPR and FPR for a range of ycut, allowing the selection of a particular ycut 
with certain sensitivity (TPR) and specificity (1-FPR). The “area under the ROC curve” 
(AUC) was also calculated which indicated the general accuracy of the screening technique 
[29]. 
3. Results 
The results are presented for four sets of predicted TSB levels including yskin, yskin,nor, yeye and 
yeye,nor as described in section 2.4. Although the main focus of this study was on using the 
sclera colour to predict TSB levels, the skin colour was included here for comparison 
purpose. 
3.1 Correlations between the measured and predicted serum bilirubin levels 
Table 1 summarises the values of Pearson’s linear correlation coefficient r and Spearman’s 
rank correlation coefficient ρ between the measured and predicted TSB levels. It can be seen 
that both the Pearson and Spearman correlations for using the sclera colour 
(normalised:0.75/0.72; un-normalised: 0.75/0.72) are much higher than those for the skin 
colour (normalised:0.54/0.50; un-normalised: 0.56/0.54). 
Figure 3 shows the scatter plots of the measured and predicted TSB levels using the sclera 
colour, i.e., Fig. 3(a), and skin colour, i.e., Fig. 3(b) as the predictors, respectively. An 
identity line is also shown in each figure which indicates that the predicted TSBs tend to 
overestimate in the lower TSB range (around 100 µmol/l) and underestimate in the higher 
TSB range (around 250 µmol/l). It can be seen that the data points are generally closer to the 
identity line using the sclera colour as the predictor (see Fig. 3(a) for yeye) in comparison to 
using the skin colour (Fig. 3(b) for yskin). 
Table 1. Correlation between the measured and predicted TSB levels 
Predicted 
Serum 
Bilirubin level 
Region of 
interest 
RGB values normalised by 
white reference colour ? 
Pearson’s linear correlation 
(r), CI: 95% Confidence 
Intervals 
Spearman’s rank 
correlation (ρ) 
yskin,nor Skin Yes 0.54 (CI: 0.39 –0.66, 
p<0.01) 
0.50 (p<0.01) 
yskin Skin No 0.56 (CI: 0.42 – 0.68, 
p<0.01) 
0.54 (p<0.01) 
yeye,nor Sclera Yes 0.75 (CI: 0.65 – 0.82, 
p<0.01) 
0.72 (p<0.01) 
yeye Sclera No 0.75 (CI: 0.65 – 0.82, 
p<0.01) 
0.72 (p<0.01) 
3.2 Bland-Altman plot 
In the previous section, it has been established that the TSB predicted by the RGB values of 
the sclera without normalisation, i.e., yeye, provides a good performance, which is the focus in 
the following analysis. Figure 4 shows the Bland-Altman plot which is often used to assess 
the agreement between two measurement methods [27]. The mean difference is close to zero 
because of the condition imposed by the least squares multiple linear regression algorithm. 
The standard deviation is 41.60 µmol/l. Although the vast majority of data points (all except 
eight) lie within the 95% confidence intervals, i.e., 0 ± 81.54 µmol/l (mean ± 1.96 standard 
deviations), the TSB differences are generally large, indicating that the predicted TSBs based 
on the sclera colour are not accurate enough to replace the TSBs by blood sampling on an 
individual basis. Similar to the scatter plots in Fig. 3, the Bland-Altman plot also shows the 
tendency of predicted TSBs overestimating in the lower TSB range and underestimating in 
the higher TSB range. Similar trends have also been found in a commercial TcB (BiliChek) 
[5]. 
 
Fig. 3. Scatter plots for the measured and predicted TSB levels based on (a) the sclera colour 
(un-normalised) and (b) the skin colour (un-normalised). The Pearson’s linear correlation (r), 
the Spearman’s rank correlation (ρ) and linear regressed lines are also shown (n = 110). 
 Fig. 4. The Bland Altman plot showing the agreement between the conventional blood 
sampling method (measurement) and the photographic method (prediction) based on the sclera 
colour: the mean difference is zero and most of the differences lie between ± 1.96 standard 
deviations, i.e., ± 81.54 µmol/l. 
3.3 Receiver operating characteristic curves 
Figure 5 depicts the ROC curve for a screening threshold (ysc) at 205 µmol/l. The optimal cut-
off threshold (ycut*) can be identified using the Youden’s J statistic which results in the 
maximum J = sensitivity + specificity - 1 = TPR – FPR [30]. This optimal point represents 
the best compromise between a high TPR and a low FPR, and is, in this case, found to be ycut* 
= 194 µmol/l (hollow circle), with sensitivity = 0.80 and specificity = 0.86. However, one can 
also choose a particular ycut to raise the sensitivity which is important in a screening test. A 
ycut at 162 µmol/l (filled circle) has been chosen to raise the sensitivity to 1.00 at the expense 
of a reduced specificity = 0.50. 
 
Fig. 5. The ROC curve for screening TSB above 205 umol/l: the optimal cut-off threshold 
(open circle) based on the Youden’s J statistic, ycut* = 194 µmol/l, resulting in sensitivity = 
0.80 and specificity = 0.86. To increase the sensitivity, the cut-off threshold is reduced to 162 
µmol/l (filled circle) which raises the sensitivity to 1.00 at the expense of a reduced specificity 
= 0.50. 
4. Discussions 
4.1 Ambient lighting 
The images taken in this study relied on the ambient lighting for illuminating the sclera, 
which inevitably also affected the prediction performance. When images taken under various 
ambient lightings were used for TSB prediction, the correlations between sclera/skin colours 
and the measured TSB were poor (result not shown here). Using the sclera samples collected 
from the same location for prediction, the correlations become much stronger as shown in 
Table 1. The results from Table 1 may first seem surprising that the normalised RGB values, 
which can also be considered to have undergone a white balancing process, do not improve 
the correlations, in comparison to the un-normalised RGB values. However, the white 
balancing is normally used to reduce the effect of colour differences under different 
illuminations. In our case, the same illumination (fluorescent light in the clinic room) has 
been used for the whole data set and therefore the need for white balancing is less important. 
In fact, the introduction of white balancing can be counterproductive because the white 
reference colour can be an additional source of noise when it receives a different illumination 
due to multipath reflections. In general, the region of interest is also affected by reflected light 
from the surrounding areas. For example, a bright colour jumper worn by the mother holding 
the baby could affect the RGB pixel values of the image. The variability of the lighting 
environment causes errors in the predicted TSB, leading to a high standard deviation of 41.60 
µmol/l in the Bland Altman plot in Fig. 4. 
4.2 Comparisons with other techniques 
Numerous studies have compared the agreement between TcB and TSB [5–16]. One review 
in 2013 summarised the results from 22 studies conducted between 1982 and 2012 ([5–16]), 
mainly on BiliChek and JM-103 (and its earlier versions) [6]. Two other studies adopted 
digital photography to predict TSB based on the skin colour in the sternum and forehead [18, 
31]. The results of these studies have been summarised in Table 2. It can be seen that the 
linear correlation coefficient r for other studies ranges between 0.83 and 0.86 while for this 
study it is lower at 0.75. The standard deviations of the mean differences reported in [6] are 
24.06 µmol/l for the sternum site and 29.46 µmol/l for the forehead site [6], in comparison to 
ours at 41.60 µmol/l for the sclera site. Our database lacks subjects with TSB values in both 
the high (>250 µmol/l) and low (<100 µmol/l) ends of the range, which may in turn affect the 
r value. 
Table 2. Comparison of result obtained by various studies (conversion for bilirubin: 1 
mg/dL = 17.1 µmol/l) 
Study Method Body site Pearson’s linear correlation, r 
(n) 
Bland-Altman test: mean 
difference a ± SD (µmol/l) 
Nagar 2013 
 [6] 
TcB: 
BiliChek, 
JM-102/103 
Forehead 
 
0.83 (n N/A; 16 pooled studies) 
−0.06 ± 29.46 (n = 912; 
11 pooled studies) 
Sternum 0.83 (n N/A; 10 pooled studies) 3.80 ± 24.06 (n = 265; 5 
pooled studies) 
Leartveravat 
2009 [31] 
Digital 
photography 
Sternum 0.86 (n = 61) N/A 
de Greef 
2014 [18] 
Digital 
photography 
Sternum & 
Forehead 
0.84 (n = 100) N/A 
Leung 2015 
(This study) 
Digital 
photography 
Sclera 0.75 (n = 110) 
 
0.00 ± 41.60 
amean difference defined as: predicted TSB – measured TSB. 
For screening purpose, the ROC curve results may be more relevant. Table 3 shows the 
ROC curve results from three studies [5, 17] including ours. A previous study found that JM-
102 performed better than BiliChek for screening subjects with a ysc = 250 µmol/l using a ycut 
= 230 µmol/l, achieving a sensitivity of 0.97 and a specificity of 0.83 [5]. Another study also 
found that JM-103 was more accurate than BiliChek in screening for subjects with a ysc = 205 
µmol/l using a ycut = 144 µmol/l, achieving a sensitivity of 1.00 and a specificity of 0.42 [17], 
which are comparable to our results: sensitivity = 1.00 and specificity = 0.50 in screening for 
subjects with a ysc = 205 µmol/l using a ycut = 162 µmol/l. Although the UK based NICE 
guidelines require the screening technique to identify patients with ysc > 250 µmol/l for 
referrals [1], we are unable to report this result because our database lacks samples above 250 
µmol/l. The AUC of our technique at 0.87 is also comparable to others’ which range between 
0.89 and 0.98. 
Table 3. Comparison of results from ROC curves 
Study Method Body 
site 
n Screening 
Threshold, 
ysc (µmol/l) 
Cut-off 
Threshold, 
ycut 
(µmol/l) 
Sensitivity Specificity AUC 
Szabo 2004 
[5] 
TcB: 
BiliChek 
Forehead 140 250 190 0.94 0.72 0.92 
 
Szabo 2004 
[5] 
TcB: JM-
102 
Sternum 140 250 230 0.97 0.83 0.98 
 
Romagnoli 
2012 [17] 
TcB: 
BiliChek 
Forehead 630 205 157 0.99 0.30 0.89 
 
Romagnoli 
2012 [17] 
TcB: JM-
103 
Forehead 630 205 144 1.00 0.42 0.94 
 
Leung 
2015 (This 
study) 
Digital 
photo-
graphy 
Sclera 110 205 162 1.00 0.50 0.87 
 
5. Conclusions 
This work has shown that by using the sclera colour to predict the TSB level, reasonably high 
correlations (r = 0.75 and ρ = 0.72) with the measured TSB can be achieved. Although the 
correlations may still not be high enough for this technique to be used to predict the absolute 
TSB level on an individual basis, it is reasonably robust as a screening technique in 
identifying subjects with TSBs above 205 µmol/l, achieving a sensitivity of 1.00 and 
specificity of 0.50, comparable to those achieved by commercial TcBs such as JM-103 and 
BiliChek [17]. In comparison to skin, sclera is less affected by other confounding factors such 
as melanin (ethnicity), allowing a relatively simple analysis technique, i.e., multiple linear 
regression, to be used in this work and still producing encouraging results. This technique can 
also be readily implemented as a low cost smartphone app, making it more accessible to the 
wider community and developing countries. Unlike the contact based TcBs which require 
disposables, this technique is non-contact, making it easier and more economical to use. 
In order to further improve the performance, in our next phase of work, certain 
improvements will be made. First, to avoid the influence of ambient light, the room light will 
be turned off and a diffuse LED flashlight will be used to gently illuminate the face of the 
baby. In this way, the photos can be taken in different locations while ensuring the same 
illumination is used. Second, the lighting environment can be better controlled by putting the 
baby in a specially designed “cot” with non-reflective surfaces, similar to the light cabinet 
(a.k.a viewing booth or light box) used in the textile industry for visual inspection of fabrics 
and garments. This environment would reduce the multipath problem and therefore minimise 
the influence of the colour objects in the surrounding on the captured images. Third, the 
algorithm can also be improved by adopting techniques such as the independent component 
analysis, which has been shown to provide a better identification of pigment colour [32]. 
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